- Email: [email protected]
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Cancer Cell
Corrections MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer Surendra K. Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V. Chaika, Enza Vernucci, Ryan J. King, Jaime Abrego, Gennifer D. Goode, Aneesha Dasgupta, Alysha L. Illies, Teklab Gebregiworgis, Bingbing Dai, Jithesh J. Augustine, Divya Murthy, Kuldeep S. Attri, Oksana Mashadova, Paul M. Grandgenett, Robert Powers, Quan P. Ly, Audrey J. Lazenby, Jean L. Grem, Fang Yu, Jose´ M. Mate´s, John M. Asara, Jung-whan Kim, Jordan H. Hankins, Colin Weekes, Michael A. Hollingsworth, Natalie J. Serkova, Aaron R. Sasson, Jason B. Fleming, Jennifer M. Oliveto, Costas A. Lyssiotis, Lewis C. Cantley, Lyudmyla Berim, and Pankaj K. Singh* *Correspondence: [email protected] http://dx.doi.org/10.1016/j.ccell.2017.08.008
(Cancer Cell 32, 71–87; July 10, 2017) In the originally published version of the paper, author Natalie J. Serkova’s name was spelled incorrectly as ‘‘Sarkova.’’ The correct spelling of the name is ‘‘Serkova,’’ and the error has been corrected in the original article online. The authors apologize for this error. ª 2017 Elsevier Inc.
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies Eric J. Small* *Correspondence: [email protected] http://dx.doi.org/10.1016/j.ccell.2017.08.009
(Cancer Cell 32, 6–8; July 10, 2017) In the originally published version of this article, the author mistakenly referred to the CHAARTED rather than the STAMPEDE trial in the title. The title has now been corrected online and reads ‘‘Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies.’’ This error is in the title only, and the text of the article is not otherwise affected. The author apologizes for any confusion that this error may have caused. ª 2017 Elsevier Inc.
392 Cancer Cell 32, 392, September 11, 2017
Corrections MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer Surendra K. Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V. Chaika, Enza Vernucci, Ryan J. King, Jaime Abrego, Gennifer D. Goode, Aneesha Dasgupta, Alysha L. Illies, Teklab Gebregiworgis, Bingbing Dai, Jithesh J. Augustine, Divya Murthy, Kuldeep S. Attri, Oksana Mashadova, Paul M. Grandgenett, Robert Powers, Quan P. Ly, Audrey J. Lazenby, Jean L. Grem, Fang Yu, Jose´ M. Mate´s, John M. Asara, Jung-whan Kim, Jordan H. Hankins, Colin Weekes, Michael A. Hollingsworth, Natalie J. Serkova, Aaron R. Sasson, Jason B. Fleming, Jennifer M. Oliveto, Costas A. Lyssiotis, Lewis C. Cantley, Lyudmyla Berim, and Pankaj K. Singh* *Correspondence: [email protected] http://dx.doi.org/10.1016/j.ccell.2017.08.008
(Cancer Cell 32, 71–87; July 10, 2017) In the originally published version of the paper, author Natalie J. Serkova’s name was spelled incorrectly as ‘‘Sarkova.’’ The correct spelling of the name is ‘‘Serkova,’’ and the error has been corrected in the original article online. The authors apologize for this error. ª 2017 Elsevier Inc.
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies Eric J. Small* *Correspondence: [email protected] http://dx.doi.org/10.1016/j.ccell.2017.08.009
(Cancer Cell 32, 6–8; July 10, 2017) In the originally published version of this article, the author mistakenly referred to the CHAARTED rather than the STAMPEDE trial in the title. The title has now been corrected online and reads ‘‘Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies.’’ This error is in the title only, and the text of the article is not otherwise affected. The author apologizes for any confusion that this error may have caused. ª 2017 Elsevier Inc.
392 Cancer Cell 32, 392, September 11, 2017